The diagnostic value of serum DSA-TRF in hepatocellular carcinoma

被引:0
|
作者
Wenqian Guan
Zhiyuan Gao
Chenjun Huang
Meng Fang
Huijuan Feng
Shipeng Chen
Mengmeng Wang
Jun Zhou
Song Hong
Chunfang Gao
机构
[1] Shanghai Eastern Hepatobiliary Surgery Hospital,Department of Laboratory Medicine
[2] Fujian Medical University,Clinical Medical College
[3] Medical School of Nanjing University,Department of Emergency Medicine, Jinling Hospital
来源
Glycoconjugate Journal | 2020年 / 37卷
关键词
Transferrin; Hepatocellular carcinoma; Glycan biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
TRF is a glycoprotein mainly secreted by hepatocytes, The aim of this study was to explore the diagnostic value of aberrant glycosylated serum transferrin (TRF) especially containing multi-antennary glycans in hepatocellular carcinoma (HCC).A total of 581 subjects including HCC patients, liver cirrhosis (LC) patients, chronic hepatitis (CHB) patients and healthy controls (HC) were recruited. All the subjects were randomly assigned to training group (n = 411) and validation group (n = 170). We firstly analyzed the serum protein N-glycome profiling of HCC, LC, and HC by DNA sequencer–assisted fluorophore-assisted carbohydrate electrophoresis (DSA-FACE) technology. We established a lectin-antibody sandwich ELISA (Lectin-ELISA) method to detect multi-antennary glycans-contained TRF (DSA-TRF) in serum, in which Datura stramonium Agglutinin (DSA) was used for specific recognition. Levels of serum DSA-TRF and TRF were analyzed respectively. The diagnostic efficacies of DSA-TRF and TRF of differentiating HCC patients from CHB, LC patients and HC within the training group were evaluated using receiver operating characteristic (ROC) curve and tested in the validation group.The result found that in training group, serum TRF and DSA-TRF levels differed significantly between HCC (1.86 ± 0.50, g/L, 0.285 ± 0.06), CHB + LC (2.39 ± 0.74, g/L, 0.189 ± 0.07) and HC (1.92 ± 0.69, g/L, 0.249 ± 0.09) (HCC vs. CHB + LC, P < 0.001; HCC vs. HC, P < 0.001; CHB + LC vs. HC, P < 0.001). The area under the ROC curve (AUC) of DSA-TRF was significantly superior to AFP (0.880, 95%CI: 0.834–0.925 vs. 0.776, 95%CI: 0.725–0.827, P = 0.003) in differentiating HCC from CHB + LC. The AUC of diagnostic model GlycoTRF1 (0.981, 95%CI: 0.969–0.993) was higher than DSA-TRF and AFP alone (P<0.001) in differentiating HCC from CHB + LC, which was verified in validation group.The results indicated that the serum DSA-TRF might serve as a potential glycan biomarker for distinguishing HCC from CHB and LC.
引用
收藏
页码:231 / 240
页数:9
相关论文
共 50 条
  • [21] Diagnostic and prognostic value of serum Chitinase 3-like protein 1 in hepatocellular carcinoma
    Wang, Shuwei
    Chen, Shixiang
    Jin, Ming
    Hu, Mengyuan
    Huang, Weiguang
    Jiang, Zhenluo
    Yang, Jianuo
    Zhang, Yecheng
    Wu, Haoming
    Hu, Yaoren
    He, Weixin
    Fu, Liyun
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (02)
  • [22] Diagnostic value of serum copper, zinc and plasma fibrinogen in cirrhotic patients with and without hepatocellular carcinoma
    Dogan, UB
    Cindoruk, M
    Dumlu, S
    Unlu, R
    Unal, S
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1997, 29 (05): : 476 - 477
  • [23] Diagnostic and prognostic value of circular RNAs in hepatocellular carcinoma
    Sun, Jin-Yu
    Zhang, Xiao-Yu
    Cao, Yi-Zhi
    Zhou, Xiao
    Gu, Jian
    Mu, Xiao-Xin
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (10) : 5438 - 5445
  • [24] Evaluation of serum thioredoxin as a hepatocellular carcinoma diagnostic marker
    Khaled Mohamed Abdelwahab
    Wesam Ahmed Ibrahim
    Shereen Abou Bakr Saleh
    Anas Abdelfattah Abdelaziz Elbarky
    Ghada Abdelrahman Mohamed
    Egyptian Liver Journal, 14
  • [25] Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma
    Zhu, Wen-Wei
    Guo, Jia-Jian
    Guo, Lei
    Jia, Hu-Liang
    Zhu, Ming
    Zhang, Ju-Bo
    Loffredo, Christopher A.
    Forgues, Marshonna
    Huang, Hua
    Xing, Xu-Jian
    Ren, Ning
    Dong, Qiong-Zhu
    Zhou, Hai-Jun
    Ren, Zheng-Gang
    Zhao, Nai-Qing
    Wang, Xin Wei
    Tang, Zhao-You
    Qin, Lun-Xiu
    Ye, Qing-Hai
    CLINICAL CANCER RESEARCH, 2013, 19 (14) : 3944 - 3954
  • [26] Serum Serotonin as a Potential Diagnostic Marker for Hepatocellular Carcinoma
    Mamdouh, Fatma
    Alem, Shereen Abdel
    Abdo, Mahmoud
    Abdelaal, Amaal
    Salem, Amel
    Rabiee, Ahmed
    Elsisi, Ola
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2019, 39 (12): : 780 - 785
  • [27] Evaluation of serum thioredoxin as a hepatocellular carcinoma diagnostic marker
    Abdelwahab, Khaled Mohamed
    Ibrahim, Wesam Ahmed
    Saleh, Shereen Abou Bakr
    Elbarky, Anas Abdelfattah Abdelaziz
    Mohamed, Ghada Abdelrahman
    EGYPTIAN LIVER JOURNAL, 2024, 14 (01)
  • [28] The Value of Serum Midkine Level in Diagnosis of Hepatocellular Carcinoma
    Shaheen, Karim Y. A.
    Abdel-Mageed, Abeer I.
    Safwat, Eslam
    AlBreedy, Ashraf M.
    INTERNATIONAL JOURNAL OF HEPATOLOGY, 2015, 2015
  • [29] Diagnostic value of serum vascular endothelial growth factor and interleukin-17 in primary hepatocellular carcinoma
    Tian, Qi
    Zeng, Hui
    Lu, Qi-Quan
    Xie, Hai-Ying
    Li, Yong
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2024, 16 (09):
  • [30] Diagnostic Value of Serum SMP30 and Anti-SMP30 Antibody in Hepatocellular Carcinoma
    Zheng, Shun-Xin
    Xiang, Bang-De
    Long, Jia-Min
    Qu, Cong
    Mo, Zhi-Jing
    Li, Kun
    Zhuang, Yuan
    Lv, Zhi-Lue
    Zhou, Su-Fang
    LABORATORY MEDICINE, 2018, 49 (03) : 203 - 210